Current Management Strategy for Metastatic Renal Cell Carcinoma and Future Directions

被引：0
|
作者：
Hussein Merza
Marijo Bilusic
机构：
[1] Fox Chase Cancer Center,National Cancer Institute
[2] Center for Cancer Research,undefined
来源：
Current Oncology Reports | 2017年 / 19卷
关键词：
Kidney cancer; Immunotherapy; Tyrosine kinase inhibitors; Targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Current Management Strategy for Metastatic Renal Cell Carcinoma and Future Directions
    Merza, Hussein
    Bilusic, Marijo
    [J]. CURRENT ONCOLOGY REPORTS, 2017, 19 (04)
  • [2] The Changing Landscape of Management of Metastatic Renal Cell Carcinoma: Current Treatment Options and Future Directions
    Nicholas J. Salgia
    Yash Dara
    Paulo Bergerot
    Meghan Salgia
    Sumanta K. Pal
    [J]. Current Treatment Options in Oncology, 2019, 20
  • [3] The Changing Landscape of Management of Metastatic Renal Cell Carcinoma: Current Treatment Options and Future Directions
    Salgia, Nicholas J.
    Dara, Yash
    Bergerot, Paulo
    Salgia, Meghan
    Pal, Sumanta K.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (05)
  • [4] Recent Advances and Future Directions in the Management of Metastatic Renal Cell Carcinoma
    Ansari, J.
    Glaholm, J.
    McMenemin, R.
    James, N. D.
    Hussain, S. A.
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2010, 10 (03) : 225 - 235
  • [5] Current management and future perspectives of metastatic renal cell carcinoma
    Lee-Ying, Richard
    Lester, Renee
    Heng, Daniel Y. C.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (09) : 847 - 855
  • [6] Targeted therapy for metastatic renal cell carcinoma: Current treatment and future directions
    Majid, Noura
    Ismaili, Nabil
    Amzerin, Mounia
    Errihani, Hassan
    [J]. CLINICAL CANCER INVESTIGATION JOURNAL, 2013, 2 (03): : 195 - 201
  • [7] Extracranial oligometastatic renal cell carcinoma: current management and future directions
    Loh, Jasmin
    Davis, Ian D.
    Martin, Jarad M.
    Siva, Shankar
    [J]. FUTURE ONCOLOGY, 2014, 10 (05) : 761 - 774
  • [8] Management of poor-risk metastatic renal cell carcinoma: current approaches, the role of temsirolimus and future directions
    Porta, Camillo
    Tortora, Giampaolo
    Larkin, James M. G.
    Hutson, Thomas E.
    [J]. FUTURE ONCOLOGY, 2016, 12 (04) : 533 - 549
  • [9] Immunotherapy for metastatic renal cell carcinoma: A brief history, current trends, and future directions
    Rambhia, Ami
    Patel, Rutul D.
    Okhawere, Kennedy E.
    Korn, Talia G.
    Badani, Ketan K.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 664 - 677
  • [10] Renal cell carcinoma: current status and future directions
    Martel, CL
    Lara, PN
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2003, 45 (02) : 177 - 190
12345